Which client would likely require the most follow-up from rifampin therapy in a community TB program?

Which client would likely require the most follow-up from rifampin therapy in a community TB program?

• A. An HIV-positive client.
• B. An elderly client with no comorbidity.
• C. A child under 5 with TB exposure only.
• D. A client with latent TB infection.

Answer: (A)

Rifampin strongly induces liver enzymes, which can dramatically reduce the levels of many antiretroviral drugs. In an HIV-positive client, this means potential loss of ART effectiveness unless therapy is adjusted and closely monitored. The follow-up needs are high to manage drug interactions, ensure any ART regimen is optimized (sometimes requiring switching rifampin to rifabutin or changing ART), and monitor for hepatotoxicity and adherence challenges with multiple medications. Because of these complexities, this client would require the most careful and ongoing follow-up in a community TB program. The other scenarios tend to involve fewer interaction issues. An elderly client without comorbidity generally requires standard monitoring unless other risk factors appear. A child under 5 with TB exposure only may not be on a full TB treatment regimen yet, or would have simpler regimens with less risk of complex drug interactions. Someone with latent TB infection typically isn’t treated with rifampin in a way that demands intensive follow-up for drug interactions, so the level of monitoring would be less demanding.

Rifampin strongly induces liver enzymes, which can dramatically reduce the levels of many antiretroviral drugs. In an HIV-positive client, this means potential loss of ART effectiveness unless therapy is adjusted and closely monitored. The follow-up needs are high to manage drug interactions, ensure any ART regimen is optimized (sometimes requiring switching rifampin to rifabutin or changing ART), and monitor for hepatotoxicity and adherence challenges with multiple medications. Because of these complexities, this client would require the most careful and ongoing follow-up in a community TB program.

The other scenarios tend to involve fewer interaction issues. An elderly client without comorbidity generally requires standard monitoring unless other risk factors appear. A child under 5 with TB exposure only may not be on a full TB treatment regimen yet, or would have simpler regimens with less risk of complex drug interactions. Someone with latent TB infection typically isn’t treated with rifampin in a way that demands intensive follow-up for drug interactions, so the level of monitoring would be less demanding.